Friday, Apr 25, 2025 · SEC filings
What the smart money revealed on Apr 25
404 insider filings came in. We hid 27 planned (10b5-1) sellers and 314 people whose filings were routine, like grants and tax withholding.
5 insiders at BioCardia (BCDA) bought $551K of stock
Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.
3 insiders at Upexi (UPXI) bought $2.15M of stock
Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.
Mineralys Therapeutics (MLYS) Director Brian Slingsby bought $3.5M
259,259 shares on the open market. Not a grant or an option exercise.
J.B. Hunt Transport Services (JBHT) EVP and COO Nicholas Hobbs bought $400K
3,038 shares on the open market. Not a grant or an option exercise.
Triumph Financial (TFIN) Director Charles Anderson bought $201K
3,950 shares on the open market. Not a grant or an option exercise.
Neogen (NEOG) Director James Borel bought $150K
30,000 shares on the open market. Not a grant or an option exercise.
Elevance Health (ELV) EVP and CFO Mark Kaye sold $1.95M
Not marked as a planned 10b5-1 sale. Sold 19% of the shares they held directly. Still holds 18,977 shares.
Nicolet Bankshares (NIC) Director Robert Atwell sold $717K
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 33,816 shares directly.
HEICO (HEI) Director Julie Neitzel sold $172K
Not marked as a planned 10b5-1 sale. Sold 63% of the shares they held directly. Still holds 418 shares.
Show 18 more real buys
Show 20 more real sales
13F season
Holdings as of Mar 31, 2025 are due May 15
92 funds have filed so far. 80 filed for the quarter before.
Biggest real insider buys, Apr 19–25
Open-market buys by officers and directors, filed in the 7 days up to Apr 25.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.